Drug Shortage Report for LENVIMA
| Report ID | 76473 |
| Drug Identification Number | 02468220 |
| Brand name | LENVIMA |
| Common or Proper name | Lenvatinib |
| Company Name | EISAI LIMITED |
| Market Status | MARKETED |
| Active Ingredient(s) | LENVATINIB |
| Strength(s) | 8MG |
| Dosage form(s) | CAPSULE |
| Route of administration | ORAL |
| Packaging size | 8mg daily-dose carton containing 6 blister cards (each 5-day blister card contains ten 4mg capsules) |
| ATC code | L01XE |
| ATC description | OTHER ANTINEOPLASTIC AGENTS |
| Reason for shortage | Demand increase for the drug. |
| Anticipated start date | |
| Actual start date | 2019-02-19 |
| Estimated end date | |
| Actual end date | 2019-02-28 |
| Shortage status | Resolved |
| Updated date | 2019-03-01 |
| Company comments | Supply of 4mg capsules available through other daily-dose configurations. Contact for more information. |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 6925 CENTURY AVE, SUITE 701 MISSISSAUGA, ONTARIO CANADA L5N 7K2 |
| Company contact information | Tammy Mitchell-Moore - Director, Regulatory Affairs 905-814-2312 / [email protected] |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v11 | 2019-03-01 | French | Compare |
| v10 | 2019-03-01 | English | Compare |
| v9 | 2019-03-01 | English | Compare |
| v8 | 2019-03-01 | English | Compare |
| v7 | 2019-03-01 | French | Compare |
| v6 | 2019-03-01 | English | Compare |
| v5 | 2019-03-01 | English | Compare |
| v4 | 2019-03-01 | English | Compare |
| v3 | 2019-02-21 | French | Compare |
| v2 | 2019-02-21 | English | Compare |
| v1 | 2019-02-21 | English | Compare |
Showing 1 to 11 of 11